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Background: The present study was designed to assess differences in the clinical and echocardiographic response to cardiac resynchronization 
therapy-defibrillator (CRT-D) among patients with diabetes mellitus and ischemic or nonischemic etiology of cardiomyopathy (ICM and NICM, 
respectively).
Methods:  Multivariate analysis was used to evaluate clinical response (defined as CRT-D vs. ICD-only reduction in the risk of heart failure [HF] 
or death) and echocardiographic response to CRT-D (defined as percent reduction in left ventricular end diastolic and systolic volume [LVEDV and 
LVESV, respectively] at 12 month of follow-up compared with baseline values) among 552 diabetic patients with ICM (n=347) or NICM (n=205) 
enrolled in MADIT-CRT.
Results:  Multivariate analysis showed that the clinical response to CRT-D was more pronounced among diabetic patients with NICM (HR=0.30 
[p<0.001] than among those with ICM (HR=0.59 [p=0.004]; p for interaction = 0.10). Consistently, Kaplan-Meier analysis showed that reduction 
in 3-year event rates with CRT-D was greater among NICM patients (Figure 1). Diabetic patients with NICM also experienced significantly greater 
reductions in LVESV and LVEDV at 12 months with CRT-D as compared with ICM patients (p<0.001 for both).
Conclusions:  In MADIT-CRT, diabetic patients with a non-ischemic etiology of cardiomyopathy experienced a more favorable clinical and 
echocardiographic response to CRT-D as compared with those who had an ischemic etiology of cardiomyopathy.
